Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features
Authors:
Open Access
- 13 August 2018
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 118 (09) , 1586-1599
Abstract
Thromboembolic events are the main cause of mortality in BCR-ABL1-negative myeloproliferative neoplasms (MPNs) but their underlying mechanisms are largely unrecognized. The Janus kinase 2 (JAK2)V617F mutation is the most frequent genetic alteration leading to MPN. Usually found in haematopoietic progenitors and stem cells, this mutation has also been described in endothelial cells (ECs) of MPN patients. In this study, we have questioned the impact of the JAK2V617F mutation on EC phenotype and functions. We developed an induced pluripotent stem cells strategy to compare JAK2 mutant and wild-type ECs. Transcriptomic assays showed that several genes and pathways involved in inflammation, cell adhesion and thrombotic events were over-represented in JAK2V617F ECs and expression levels of von Willebrand factor and P-selectin (CD62P) proteins were increased. Finally, we found that leucocytes from MPN patients adhere more tightly to JAK2V617F ECs. Our results show that JAK2V617F ECs have a pro-inflammatory and pro-thrombotic phenotype and were functionally pro-adherent. * These authors contributed equally to this work. ** Jean-Jacques Kiladjian co-supervised the study.Keywords
This publication has 47 references indexed in Scilit:
- The promise of induced pluripotent stem cells in research and therapyNature, 2012
- Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flowBlood, 2011
- New mutations and pathogenesis of myeloproliferative neoplasmsBlood, 2011
- Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasmsBlood, 2011
- Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disordersBlood, 2009
- Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cellsNature, 2009
- The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndromeBlood, 2009
- The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 casesBlood, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005